Sally M. El‐Hefnawy

COVID-19 susceptibility, severity, clinical outcome and Toll-like receptor (7) mRNA expression driven by TLR7 gene polymorphism (rs3853839) in middle-aged individuals without previous comorbidities

Sally M. El‐Hefnawy, Hanaa A. Eid, Rasha G. Mostafa et al. · Gene Reports · 2022 · 34 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Mi-RNA-93 and Mi-RNA-152 in the Diagnosis of Type 2 Diabetes and Diabetic Retinopathy

Amany A. Saleh, Sally M. El‐Hefnawy, Zeinab A. Kasemy et al. · British Journal of Biomedical Science · 2022 · 24 citations · Full text

Medicine, Endocrinology, Molecular Medicine +16

Circulating long noncoding RNA growth arrest‐specific transcript 5 as a diagnostic marker and indicator of degree of severity in plaque psoriasis

Wafaa Ahmed Shehata, Alaa Hassan Maraee, Manal Abd El Monem Ellaithy et al. · International Journal of Dermatology · 2021 · 20 citations

Medicine, Dermatology, Molecular Medicine +17

Simultaneous Assessment of MicroRNAs 126 and 192 in Diabetic Nephropathy Patients and the Relation of these MicroRNAs with Urinary Albumin

Safaa I. Tayel, Amany A. Saleh, Sally M. El‐Hefnawy et al. · Current Molecular Medicine · 2019 · 19 citations

Medicine, Endocrinology, Nephrology +15

Biochemical and molecular study on serum miRNA-16a and miRNA- 451 as neonatal sepsis biomarkers

Sally M. El‐Hefnawy, Rasha G. Mostafa, Rania S. El zayat et al. · Biochemistry and Biophysics Reports · 2021 · 14 citations · Full text

Veterinary Medicine, Molecular Biology, Pediatrics +17